Ç°ÑÔ
²¡¶¾ÐÔ¸ÎÑ×(viral hepatitis)ÊÇÓɶàÖÖ²î±ð¸ÎÑײ¡¶¾ÒýÆðµÄÒ»×éÒÔ¸ÎÔàËðº¦ÎªÖ÷µÄѬȾ²¡£¬¿É·ÖΪ¼×¡¢ÒÒ¡¢±û¡¢¶¡¡¢Îì¡¢¸ýÁùÖÖÀàÐÍ£¬¸÷ÐÍÖ®¼äÎÞ½»Ö¯ÃâÒߣ¬¿Éͬʱ»òÏȺóѬȾ£¬»ìÏýѬȾ»òÖصþѬȾ£¬Ê¹Ö¢×´¼ÓÖØ¡£¼×ÐͲ¡¶¾ÐÔ¸ÎÑ׺ÍÎìÐͲ¡¶¾ÐÔ¸ÎÑ×ÒԷࣿÚÈö²¥ÎªÖ÷£¬³£¼û·¢ÈÈ¡¢»Æ¾Ò£¬³Ê¼±ÐÔ¾ÓÉ£¬ÓÐÊýǨÑÓ³ÉÂýÐÔ£»ÒÒÐͲ¡¶¾ÐÔ¸ÎÑ׺ͱûÐͲ¡¶¾ÐÔ¸ÎÑ×£¬¶à¾ÊäѪ»òѪÖÆÆ·ÒÔ¼°Ç×½ü½Ó´¥Èö²¥£¬Ò×ǨÑÓÉú³¤³ÉÂýÐÔÉõÖÁ¸ÎÓ²»¯£¬ÒÑ֤ʵÒÒÐͺͱûÐ͸ÎÑײ¡¶¾Ñ¬È¾Óë¸Î°©ÓÐÒ»¶¨¹Øϵ£»¶¡ÐͲ¡¶¾ÐÔ¸ÎÑ×ÐèÒÀÀµÓÚÒÒÐ͸ÎÑײ¡¶¾¶ø±£´æ²¢¸´ÖÆ£¬³£ÓëÒÒÐ͸ÎÑײ¡¶¾³Ê»ìÏýѬȾ»òÔÚÒÒÐ͸ÎÑײ¡¶¾ÑôÐÔµÄÂýÐÔÒҸβ¡³ÌÖÐÖصþѬȾ¡£ÏÖÔÚ½¨ÉèµÄ²¡¶¾ÐÔ¸ÎÑ׶¯ÎïÄ£×ÓÖ÷ÒªÓм×Ð͸ÎÑײ¡¶¾Ä£×Ó¡¢ÒÒÐ͸ÎÑײ¡¶¾Ä£×Ó¡¢±ûÐ͸ÎÑ× ²¡¶¾Ä£×ÓºÍÎìÐ͸ÎÑײ¡¶¾Ä£×Ó¡£
¼×Ð͸ÎÑ×(hepatitis A)ÊÇÓÉÓÚѬȾ¼×Ð͸ÎÑײ¡¶¾(hepatitis A virus, HAV)Ëùµ¼ÖµÄÒ»ÖÖѬȾÐԵĸÎÔ༲²¡¡£HAVÊÇÒ»ÖÖСRNA²¡¶¾¡£¼×Ð͸ÎÑ×µÄÈö²¥Í¾¾¶Îª·à£¿ÚÈö²¥£¬Ò²¿ÉÄÜÒòѪҺѬȾÒýÆð¡£¼×Ð͸ÎÑ×µÄÖ¢×´Óз¢ÈÈ¡¢Æ£ÀÍ¡¢Ê³Óû²»Õñ¡¢¶ñÐÄÍÂÄæ¡¢¸¹Í´¡¢Ð¡±ã»Æ³à¡¢ÊàŦʹ¡¢»Æ¾ÒµÈ¡£Ñ¬È¾¼×Ð͸ÎÑײ¡¶¾2~6ÖÜÖ®ºóÓÐЩÈ˻᷺ÆðÉÏÊöÖ¢×´£¬Ò»Ñùƽ³£³ÉÄêÈ˵ÄÖ¢×´±È¶ùͯҪÏÔ×Å¡£´ó²¿·Ö¼×Ð͸ÎÑ×»¼Õß¾ÓÉÖÎÁÆȬÓúºó²¢²»»áÓÐÒ»Á¬ÐԵĸÎÔàËðÉË£¬ÉÙÉÙ»¼Õß(50ËêÒÔÉÏ»òÕß°éÓÐÒҸλò±û¸ÎµÄÈËȺ£©»á±¬·¢¸ÎË¥½ßºÍéæÃü¡£¹ú¼ÊÉÏÒ»Ñùƽ³£Óõļ×Ð͸ÎÑײ¡¶¾¶¯ÎïÄ£×ӵĶ¯ÎïÖ÷ÒªÓÐáõºï¡¢ºãºÓºï¡¢Ê³Ð·ºï¡¢Ê÷üšµÈ¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯Îʳзºï
¡¾ÔìÄ£»úÖÆ¡¿£º
¼×Ð͸ÎÑ×Ö÷Òª¾·à£¿Ú;¾¶£¨Ïû»¯µÀ£©Èö²¥£¬ÆäËû;¾¶ÓÐѪҺÈö²¥¡¢±ÊÖ±Èö²¥µÈ¡£Ê¹Óü×Ð͸ÎÑ×µÄÈö²¥Ìص㣬ͨ¹ýÏò¶¯Îï¾²Âö×¢Éä¼×Ð͸ÎÑ×»¼ÕßÐÂÏÊ´ó±ãÂËÒº»òÏò¶¯Îï¹àθ¼×Ð͸ÎÑ×»¼ÕßÐÂÏÊ´ó±ãÐüÒºµÄÒªÁìÓÕµ¼¶¯Îﱬ·¢ÀàËÆÓÚÈËÀà×ÔȻѬȾ¼×Ð͸ÎÑײ¡¶¾ºóµÄ¼²²¡Àú³Ì¡£
¡¾ÔìÄ£ÒªÁì¡¿£º
¼×¸Î»¼ÕߵĴó±ãÑùÆ·ÓÃPBS(10nMÁ×ËáÄÆ£¬0.15M NaCl)¼°ÅÌÄáÎ÷ÁÖ(100IU/ml£©ºÍÁ´Ã¹ËØ(100mg/ml)Ï¡ÊͳÉŨ¶È1£¥µÄÒºÌ壬µÍËÙÀëÐĺóµÄÉÏÇåÒºÓÃ0.45µmÂËĤ¹ýÂË£¬ÓÃøÁªÃâÒßÒÇÎü¸½·¨ºÍʵʱ¶¨Á¿PCR·¨¼ì²âHAV¹ýÂËÒº£¬ÊµÑé×é¾²Âö×¢Éä0.5ml²¡¶¾¹ýÂËÒº£¬±ÈÕÕ×éÓÃÕý·²È˵Ĵó±ã¹ýÂËÒº¡£
¡¾Ä£×ÓÌص㡿£º
ʳзºï(crab-eating macaque)ѬȾHAVºó£¬±û°±Ëáת°±Ã¸(ALT)ÔÚµÚ7Ìì×îÏÈÉý¸ß£¬20ÌìʱµÖ´ï·åÖµ£¬lgMºÍ×ܵÄHAV¿¹ÌåÔÚµÚ14Ììʱ×îÏÈÔöÌí£¬µÚ20ÌìµÖ´ï·åÖµ£¬Ö®ºó»ºÂý»ØÂä¡£µÚ7Ìì¼´¿ÉÔÚ·à±ãÖмì³öHAVºËËᣬµÚ15Ìì·à±ãÖв¡¶¾ÔØÁ¿´ï105¿½±´£¯ml,µÚ20ÌìʱѪÇåÖÐÔØÁ¿´ï104¿½±´£¯ml£¬µÚ7ÌìÍÙÒºÖÐÔØÁ¿´ï103¿½±´/ml¡£¸ÎÔàºÍÍÙÒºÏÙÖпÉÔÚѬȾµÚ7~60ÌìÒ»Á¬¼ì²âµ½HAV¿¹Ô¡£HAV¸´ÖƵÄÖÐÐIJúÆ·¿ÉÔڸΡ¢ÍÙÒºÏÙ¡¢±âÌÒÌåºÍÁÜͶºÏÖмì²âµ½£¬ÍÙÒºÏÙ¿É×÷Ϊ¸ÎÍâHAVÔçÆÚ¸´ÖƵİÐÆ÷¹Ù¡£¸Î×éÖ¯²¡Àíѧ¼ì²âÏÔʾ¸Îϸ°û·ºÆðÖ×ÕÍ£¬»ã¹ÜÇø¿É¼ûÑ×ϸ°û½þÈó¡£
¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º
ʳзºïÔÚϵͳ½ø»¯ºÍÃâÒßµ÷Àí·½ÃæÏà±ÈÓÚÄö³Ý¶¯Îï¸ü¿¿½üÓÚÈË£¬¸üÄÜÖ±¹ÛµØ·´Ó¦³öѬȾºóÀàËÆÓÚÈ˵ĻúÌåµÄÃâÒßµ÷Àí¼°²¡¶¾¸´ÖÆÇéÐΣ¬¿ÉÓÃÓڼ׸ÎÖ²¡»úÖÆÑо¿ºÍ¼×¸ÎÒßÃçµÄЧÓÃÆÀ¼Û¡£
²Î¿¼ÎÄÏ×£º
1.Äϴ󺽣¬ÅËÄþ£¬ÕŽ¨Çí£®ÒÒÐ͸ÎÑ׶¯ÎïÄ£×ÓÑо¿Ï£Íû. ¶«ÄÏ´óѧѧ±¨£¨Ò½Ñ§°æ£©£¬2012, 31 (4):504-507
2.¹¢¼Ò±¦£¬ÍõÁᣬÖìÓÀºì£®ÊµÑéѬȾÎìÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÖйúÔ¤·ÀҽѧÔÓÖ¾£¬2010, 11(4):429-432
3.Õ²ÃÀÔÆ£¬Áõ³ç°Ø£¬Àî³ÉÃ÷£¬µÈ£®¼×Ð͸ÎÑײ¡¶¾Ñ¬È¾Ê÷üšµÄÆðÔ´Ñо¿£®Öйúҽѧ¿ÆѧԺѧ±¨£¬1981, 3 (3):148-152
4.Amado LA, Marchevsky RS,de Paula VS, el al. Experimental hepatitis A virus (HAV) infection in cynomolgus monkeys (Macaca fascicularÐÄ£ºevidence of active exlranepaticsite of HAV replication.Int J Exp Pathol, 2010, 91 (1):87-97
5.Dand.ri M, Burda MR, Torok E, et al. Repopulation of mouse Liver with human hepatocytes and in vivo infection wilh hepatilis B virus. Hepatology, 2001, 33 (4):981-988
6.Dorner M,Horwilz JA,Robbins JB,el al. A genetically humanized mouse model for hepatitis C virus Infection.Nature,2011,474(7350):208-211
7.Maneeral. Y, Clayson ET, Myint KS, et al. Experimental infection of the lahoratory rat with the hepatitis e virus. J Med Virol, 1996,48 (2): 121-128
8.Purcell RH, Emerson SU. Emerson. Animal Models of Hepatitis A and E. ILAR J, 2001, 42 (2): 161-177